Emyria Limited (ASX:EMD)

Dr Michael Winlo
Market Cap (AUD): 59.13M
Sector: Health Care
Last Trade (AUD): 0.215 +0 (+0%)
Tab Bar

1. About

Emyria Limited (ASX:EMD), formerly Emerald Clinics Limited, is a data-backed, drug development company targeting unmet needs.

Emyria’s drug development programs are focused on obtaining formal registration with major global regulators and are informed by insights generated from extensive analysis of Emyria Data - deep, ethically-sourced clinical and real-world evidence that is gathered with patients across Emyria’s independent clinical services - Emerald Clinics

Emyria Data provides deep treatment insights and is therefore a source of unique IP, strategically designed drug development and personalised care programs.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk